האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

roche registration gmbh - mosunetuzumab - eitilæxli, follicular - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.

האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

immunocore ireland limited - tebentafusp - uveal neoplasms - Æxlishemjandi lyf - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - topiramatum inn - filmuhúðuð tafla - 100 mg

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - topiramatum inn - filmuhúðuð tafla - 200 mg

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - topiramatum inn - filmuhúðuð tafla - 25 mg

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - topiramatum inn - filmuhúðuð tafla - 50 mg

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - topiramatum inn - hart hylki - 15 mg

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - topiramatum inn - filmuhúðuð tafla - 25 mg

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - topiramatum inn - filmuhúðuð tafla - 50 mg

האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

roche registration gmbh  - glofitamab - lymphoma, large b-cell, diffuse - Æxlishemjandi lyf - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.